GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_11880/2025

Alexion Pharmaceuticals, Inc.

Datum
2025-06-19
Kammer
Luxembourg (LU)
Verfahrensart
Generic application
Sprache
EN

Metadaten

Fall-IDORD_11880-2025-972c2f334a2b
Aktenzeichen
RegisterzeichenORD_11880/2025
EntscheidungsreferenzORD_11880/2025
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 6

1 Decision of the Court of Appeal of the Unified Patent Court issued on 19 June 2025 concerning an Application for rehearing (R. 245 RoP) HEADNOTES The Court of Appeal sets out the general principles to be considered when deciding on a request for a rehearing based on a fundamental procedural defect pursuant to Art. 81(1)(b) UPCA jo. R. 247(c) RoP (fundamental procedural defect; fundamental violation of Art. 76 UPCA) KEYWORDS Rehearing (Art. 81(1) UPCA; R. 245 RoP); fundamental procedural defect APPLICANT AND APPELLANT (AND APPLICANT IN THE PROCEEDINGS BEFORE THE COURT OF FIRST INSTANCE) Alexion Pharmaceuticals, Inc., 121 Seaport Blvd, 02210 Boston (MA), USA hereinafter (“Alexion”) represented by attorney-at-law Elena Hennecke , as sisted by other attorneys -at-law of Freshfields, Düsseldo ...